Heyholder
‹ Activism Filings

Curiox Biosystems Co., Ltd. Q3 revenue KRW 1.5 billion, operating loss KRW 3.9 billion

Curiox Biosystems Co., Ltd.· Periodic Report

AI summary · Not investment advice

Curiox Biosystems sold KRW 1.5 billion in Q3 but lost KRW 3.9 billion from its main business; sales rose 7.8% from a year earlier and 26.9% from the prior quarter.

Operating profit · 3 months

KRW -3.9 billion

Key facts

Revenue (3 months)
KRW 1.5 billion
Net income (3 months)
KRW -5.3 billion
Period
Q3 (cumulative 2026.01.01 ~ 2026.09.30)
Revenue (prior-year 3 months)
KRW 1.4 billion
Revenue (year to date)
KRW 4.0 billion
Operating profit (prior-year 3 months)
KRW -2.7 billion
Operating profit (year to date)
KRW -11.6 billion
Net income (prior-year 3 months)
KRW -3.0 billion
Net income (year to date)
KRW -12.8 billion

Commentary

AI commentary · Not investment advice

What happened

Curiox Biosystems reported its consolidated results for the third quarter of 2026. Sales for the latest 3 months were KRW 1.49 billion. That compares with KRW 1.38 billion in the same 3 months a year earlier. Sales rose 7.8% from a year earlier and 26.9% from the previous quarter. Cumulative sales this year are KRW 3.99 billion.

In the company's terms

Operating profit (profit from the core business) for the 3 months was a loss of KRW 3.92 billion. A year earlier the loss was KRW 2.68 billion. The cumulative operating loss this year is KRW 11.62 billion.

What changes for shareholders

Net income (the final profit after taxes and all other items) for the 3 months was a loss of KRW 5.31 billion. A year earlier the loss was KRW 3.03 billion. The cumulative net loss this year is KRW 12.79 billion.

Comments

No comments yet

Comments from shareholders will appear here.